Progenity Says Progresses Its Drug Delivery System Clinical Device Performance Studies; Says Study Is Recruiting
Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, today announced progress with its clinical device performance study plan, evaluating the device function and safety of its Drug Delivery